Increased Levels of Asymmetric Dimethylarginine (ADMA) in Patients with Ankylosing Spondylitis

Abstract

The increased ADMA levels obtained in a group of relatively young AS patients who did not have classical CV risk factors suggest that NO metabolism is impaired in AS. On the other hand, anti-TNF treatments may have a beneficial effect on vascular function in AS.